These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 6864917)

  • 41. Molecular epidemiology of bladder cancer.
    Vineis P; Martone T
    Ann Ist Super Sanita; 1996; 32(1):21-7. PubMed ID: 8967722
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Acetylation phenotype, carcinogen-hemoglobin adducts, and cigarette smoking.
    Vineis P; Caporaso N; Tannenbaum SR; Skipper PL; Glogowski J; Bartsch H; Coda M; Talaska G; Kadlubar F
    Cancer Res; 1990 May; 50(10):3002-4. PubMed ID: 2334904
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Acetylator phenotyping in patients with malignant lymphomas, using caffeine as the metabolic probe.
    William BM; Abdel-tawab AM; Hassan EA; Mohamed OF
    Pol J Pharmacol; 2004; 56(4):445-9. PubMed ID: 15520499
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Association of NAT2, GSTM1, GSTT1, CYP2A6, and CYP2A13 gene polymorphisms with susceptibility and clinicopathologic characteristics of bladder cancer in Central China.
    Song DK; Xing DL; Zhang LR; Li ZX; Liu J; Qiao BP
    Cancer Detect Prev; 2009; 32(5-6):416-23. PubMed ID: 19303722
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Familial transitional cell carcinoma.
    Kiemeney LA; Schoenberg M
    J Urol; 1996 Sep; 156(3):867-72. PubMed ID: 8709350
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GSTO1*C/GSTO2*G haplotype is associated with risk of transitional cell carcinoma of urinary bladder.
    Djukic T; Simic T; Radic T; Matic M; Pljesa-Ercegovac M; Suvakov S; Coric V; Pekmezovic T; Novakovic I; Dragicevic D; Savic-Radojevic A
    Int Urol Nephrol; 2015 Apr; 47(4):625-30. PubMed ID: 25716313
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Frequent expression of zinc-finger protein ZNF165 in human urinary bladder transitional cell carcinoma.
    Singh PK; Srivastava AK; Dalela D; Rath SK; Goel MM; Bhatt ML
    Immunobiology; 2015 Jan; 220(1):68-73. PubMed ID: 25214475
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Methylation patterns of Rb1 and Casp-8 promoters and their impact on their expression in bladder cancer.
    Malekzadeh K; Sobti RC; Nikbakht M; Shekari M; Hosseini SA; Tamandani DK; Singh SK
    Cancer Invest; 2009 Jan; 27(1):70-80. PubMed ID: 19160091
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular pathology of low malignant bladder transitional cell carcinoma: a current perspective.
    Wang HT; Chang JW
    Histol Histopathol; 2005 Jan; 20(1):147-53. PubMed ID: 15578434
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Relationship between acetylator status, smoking, and diet and colorectal cancer risk in the north-east of England.
    Welfare MR; Cooper J; Bassendine MF; Daly AK
    Carcinogenesis; 1997 Jul; 18(7):1351-4. PubMed ID: 9230278
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [The prognostic significance of the PCNA protein in transitional-cell bladder cancer].
    Gaĭyrov AG; Klimenko IA; Grigorenko VM; Nepomniashchiĭ VN; Bazalitskaia SV
    Lik Sprava; 1999; (1):64-7. PubMed ID: 10424002
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Exon 2 methylation inhibits hepaCAM expression in transitional cell carcinoma of the bladder.
    Pan C; Wu X; Luo C; Yang S; Pu J; Wang C; Shen S
    Urol Int; 2010; 85(3):347-54. PubMed ID: 20628239
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SOX4 expression levels in urothelial bladder carcinoma.
    Gunes S; Yegin Z; Sullu Y; Buyukalpelli R; Bagci H
    Pathol Res Pract; 2011 Jul; 207(7):423-7. PubMed ID: 21680105
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The polyAT, intronic IVS11-6 and Lys939Gln XPC polymorphisms are not associated with transitional cell carcinoma of the bladder.
    Sak SC; Barrett JH; Paul AB; Bishop DT; Kiltie AE
    Br J Cancer; 2005 Jun; 92(12):2262-5. PubMed ID: 15886698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association of N-acetyltransferase polymorphism and environmental factors with bladder carcinogenesis. Study in a north German population.
    Hanssen HP; Agarwal DP; Goedde HW; Bucher H; Huland H; Brachmann W; Ovenbeck R
    Eur Urol; 1985; 11(4):263-6. PubMed ID: 4043164
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [The prognostic importance of the immunohistochemical study of protein p53 in transitional-cell bladder tumors].
    Gaĭyrov AG; Romanenko AM; Klimenko IA; Sakalo VS; Grigorenko VN; Nepomniashchiĭ VN
    Lik Sprava; 1998; (5):86-9. PubMed ID: 9793315
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Identification and kinetic characterization of acetylator genotype-dependent and -independent arylamine carcinogen N-acetyltransferases in hamster bladder cytosol.
    Yerokun T; Kirlin WG; Trinidad A; Ferguson RJ; Ogolla F; Andrews AF; Brady PK; Hein DW
    Drug Metab Dispos; 1989; 17(3):231-7. PubMed ID: 2568902
    [TBL] [Abstract][Full Text] [Related]  

  • 58. N-acetyltransferase activity--a susceptibility factor in human bladder carcinogenesis.
    Dewan A; Chattopadhyay P; Kulkarni PK
    Indian J Cancer; 1995 Mar; 32(1):15-9. PubMed ID: 7558106
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Splicing variants of carbonic anhydrase IX in bladder cancer and urine sediments.
    Malentacchi F; Vinci S; Della Melina A; Kuncova J; Villari D; Giannarini G; Nesi G; Selli C; Orlando C
    Urol Oncol; 2012; 30(3):278-84. PubMed ID: 20875751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
    Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
    Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.